Varicose Vein Treatments: Global Markets
Report Scope:
Varicose veins treatment includes procedure types such as sclerotherapy, endovenous ablation and surgical procedures. This report is an analytical business tool that offers a thorough evaluation of the global market.
The format of this study includes -
Varicose veins treatment includes procedure types such as sclerotherapy, endovenous ablation and surgical procedures. This report is an analytical business tool that offers a thorough evaluation of the global market.
The format of this study includes -
- Detailed descriptions of the disease including classification, anatomy, pathophysiology and risk factors.
- Detailed descriptions and analyses of treatments and procedures
- Market characterization, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2026.
- Key marketed products along with information about their regulatory status.
- Analysis of regulatory structure.
- Discussions about the future of varicose vein treatments.
- Profiles of market participants.
- An overview of the global varicose veins treatment market
- Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Estimation of the current market size and market forecast for varicose veins treatment, and corresponding market share analysis by product type, end user and geographic region
- Evaluation of the impact of demographic, economic, and other factors that will drive future demand for the market
- Impact of COVID-19 on the medical devices market as well as market for vascular surgery and venous procedures
- Highlights of current and future market potential of generic drugs along with a detailed review of technology updates, regulatory scenario and product pipeline analysis within the marketplace
- Company profiles of the market leading participants
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview of Disease
Risk Factors, Anatomy, and Pathophysiology
Risk Factors
Anatomy
Pathophysiology
Clinical Presentation
Diagnosis
Clinical Examination
Role of Imaging
Prognosis
Management of Varicose Veins
Lifestyle Modification
Compression Therapy
Sclerotherapy
Endovenous Ablation Therapy
Surgical Options
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Prevalence of Obesity
Prevalence of Deep Vein Thrombosis
Incidence of Chronic Venous Diseases
Minimally Invasive Surgical Procedures
Growing Markets: Emerging Economies
Restraints and Challenges
Changing Decision Makers
Influence of New Entities
Price Pressure
Regulatory Environment
Compliance Rules
End Users: Lack of Training
CHAPTER 5 IMPACT OF COVID-19 ON THE GLOBAL MARKET
Introduction
Outbreak
Symptoms of COVID-19
Incubation Period
Impact of COVID-19 on the Medical Device Market
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Impact of COVID-19 on Vascular Surgery and Venous Procedures
The Status Quo Disrupted
CHAPTER 6 REGULATORY SCENARIO
Regulations and Legislation
Europe
U.S.
Japan
CHAPTER 7 MARKET SIZE AND ANALYSIS
Market Breakdown by Product Type
Overview
Endovenous Ablation
Sclerotherapy
Surgical Ligation and Stripping
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 8 COMPANY PROFILES
ANGIODYNAMICS INC.
BIOLITEC AG
BOSTON SCIENTIFIC CORP.
CANDELA MEDICAL
ENERGIST MEDICAL GROUP
EUFOTON SRL
MEDTRONIC
QUANTA SYSTEM S.P.A.
TELEFLEX INC.
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview of Disease
Risk Factors, Anatomy, and Pathophysiology
Risk Factors
Anatomy
Pathophysiology
Clinical Presentation
Diagnosis
Clinical Examination
Role of Imaging
Prognosis
Management of Varicose Veins
Lifestyle Modification
Compression Therapy
Sclerotherapy
Endovenous Ablation Therapy
Surgical Options
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Prevalence of Obesity
Prevalence of Deep Vein Thrombosis
Incidence of Chronic Venous Diseases
Minimally Invasive Surgical Procedures
Growing Markets: Emerging Economies
Restraints and Challenges
Changing Decision Makers
Influence of New Entities
Price Pressure
Regulatory Environment
Compliance Rules
End Users: Lack of Training
CHAPTER 5 IMPACT OF COVID-19 ON THE GLOBAL MARKET
Introduction
Outbreak
Symptoms of COVID-19
Incubation Period
Impact of COVID-19 on the Medical Device Market
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Impact of COVID-19 on Vascular Surgery and Venous Procedures
The Status Quo Disrupted
CHAPTER 6 REGULATORY SCENARIO
Regulations and Legislation
Europe
U.S.
Japan
CHAPTER 7 MARKET SIZE AND ANALYSIS
Market Breakdown by Product Type
Overview
Endovenous Ablation
Sclerotherapy
Surgical Ligation and Stripping
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 8 COMPANY PROFILES
ANGIODYNAMICS INC.
BIOLITEC AG
BOSTON SCIENTIFIC CORP.
CANDELA MEDICAL
ENERGIST MEDICAL GROUP
EUFOTON SRL
MEDTRONIC
QUANTA SYSTEM S.P.A.
TELEFLEX INC.
LIST OF TABLES
Summary Table: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 1: Risk Factors for Varicose Veins
Table 2: CEAP Classification System and Reporting Standards for Vascular Diseases
Table 3: Incidence of Complications after Different Modalities of Varicose Vein Treatments
Table 4: BMI Categories Based on Increasing Health Risks
Table 5: Trends in Obesity in the World’s Population, by Segment, Through 2021
Table 6: U.S. Obesity and Severe Obesity vs. the General Adult Population, by Segment, Through 2021
Table 7: Distribution of Clinical Symptoms of COVID-19
Table 8: Class I and II Exempt Devices
Table 9: CPT Codes for Endovenous Ablation
Table 10: CPT Codes for Ambulatory Phlebectomy
Table 11: CPT Codes for Ligation and Stripping
Table 12: CPT Codes for Endoscopic Ligation and Stripping of Perforating Vein
Table 13: CPT Codes for Sclerotherapy
Table 14: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 15: Approved Endovenous Ablation Devices
Table 16: Global Market for Varicose Vein Treatments, by Region, Through 2026
Table 17: North American Market for Varicose Vein Treatments, by Type, Through 2026
Table 18: North American Market for Varicose Vein Treatments, by Country, Through 2026
Table 19: North American Market for Varicose Vein Treatments, by End User, Through 2026
Table 20: European Market for Varicose Vein Treatments, by Type, Through 2026
Table 21: European Market for Varicose Vein Treatments, by Country, Through 2026
Table 22: European Market for Varicose Vein Treatments, by End User, Through 2026
Table 23: Asia-Pacific Market for Varicose Vein Treatments, by Type, Through 2026
Table 24: Asia-Pacific Market for Varicose Vein Treatments, by Country, Through 2026
Table 25: Asia-Pacific Market for Varicose Vein Treatments, by End User, Through 2026
Table 26: RoW Market for Varicose Vein Treatments, by Type, Through 2026
Table 27: RoW Market for Varicose Vein Treatments, by End User, Through 2026
Table 28: AngioDynamics: Financials, 2018-2020
Table 29: Boston Scientific Corp.: Product Portfolio
Table 30: Boston Scientific Corp.: Recent Developments, 2015-2020
Table 31: Medtronic: Product Portfolio
Table 32: Medtronic: Varicose Vein Treatment Devices
Table 33: Medtronic: Revenue, 2018-2020
Summary Table: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 1: Risk Factors for Varicose Veins
Table 2: CEAP Classification System and Reporting Standards for Vascular Diseases
Table 3: Incidence of Complications after Different Modalities of Varicose Vein Treatments
Table 4: BMI Categories Based on Increasing Health Risks
Table 5: Trends in Obesity in the World’s Population, by Segment, Through 2021
Table 6: U.S. Obesity and Severe Obesity vs. the General Adult Population, by Segment, Through 2021
Table 7: Distribution of Clinical Symptoms of COVID-19
Table 8: Class I and II Exempt Devices
Table 9: CPT Codes for Endovenous Ablation
Table 10: CPT Codes for Ambulatory Phlebectomy
Table 11: CPT Codes for Ligation and Stripping
Table 12: CPT Codes for Endoscopic Ligation and Stripping of Perforating Vein
Table 13: CPT Codes for Sclerotherapy
Table 14: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 15: Approved Endovenous Ablation Devices
Table 16: Global Market for Varicose Vein Treatments, by Region, Through 2026
Table 17: North American Market for Varicose Vein Treatments, by Type, Through 2026
Table 18: North American Market for Varicose Vein Treatments, by Country, Through 2026
Table 19: North American Market for Varicose Vein Treatments, by End User, Through 2026
Table 20: European Market for Varicose Vein Treatments, by Type, Through 2026
Table 21: European Market for Varicose Vein Treatments, by Country, Through 2026
Table 22: European Market for Varicose Vein Treatments, by End User, Through 2026
Table 23: Asia-Pacific Market for Varicose Vein Treatments, by Type, Through 2026
Table 24: Asia-Pacific Market for Varicose Vein Treatments, by Country, Through 2026
Table 25: Asia-Pacific Market for Varicose Vein Treatments, by End User, Through 2026
Table 26: RoW Market for Varicose Vein Treatments, by Type, Through 2026
Table 27: RoW Market for Varicose Vein Treatments, by End User, Through 2026
Table 28: AngioDynamics: Financials, 2018-2020
Table 29: Boston Scientific Corp.: Product Portfolio
Table 30: Boston Scientific Corp.: Recent Developments, 2015-2020
Table 31: Medtronic: Product Portfolio
Table 32: Medtronic: Varicose Vein Treatment Devices
Table 33: Medtronic: Revenue, 2018-2020
LIST OF FIGURES
Summary Figure: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 1: Trends in Obesity in the World's Population, by Segment, 2012-2021
Figure 2: U.S. Obesity and Severe Obesity vs. General Population, by Segment, 2016 and 2021
Figure 3: Medical Device Marketing Process in the U.S.
Figure 4: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 5: Global Market for Endovenous Ablation Devices, 2020-2026
Figure 6: Global Market Shares of Endovenous Ablation Devices, by Type, 2020
Figure 7: Global Market for Sclerotherapy Treatments, 2020-2026
Figure 8: Global Market Shares of Sclerotherapy Treatments, by Type, 2020
Figure 9: Global Market for Surgical Ligation and Stripping, 2020-2026
Figure 10: Global Market Shares of Varicose Vein Treatments, by Region, 2020
Figure 11: AngioDynamics: Revenue Share, by Segment, 2020
Figure 12: AngioDynamics: Revenue Share, by Region/Country, 2020
Summary Figure: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 1: Trends in Obesity in the World's Population, by Segment, 2012-2021
Figure 2: U.S. Obesity and Severe Obesity vs. General Population, by Segment, 2016 and 2021
Figure 3: Medical Device Marketing Process in the U.S.
Figure 4: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 5: Global Market for Endovenous Ablation Devices, 2020-2026
Figure 6: Global Market Shares of Endovenous Ablation Devices, by Type, 2020
Figure 7: Global Market for Sclerotherapy Treatments, 2020-2026
Figure 8: Global Market Shares of Sclerotherapy Treatments, by Type, 2020
Figure 9: Global Market for Surgical Ligation and Stripping, 2020-2026
Figure 10: Global Market Shares of Varicose Vein Treatments, by Region, 2020
Figure 11: AngioDynamics: Revenue Share, by Segment, 2020
Figure 12: AngioDynamics: Revenue Share, by Region/Country, 2020
